N. Finkler

发表

Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery

R. Holloway, Lorna A. Brudie, Giorgia Gaia, 2012, Journal of Robotic Surgery.

A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.

A. Secord, L. Havrilesky, G. Broadwater, 2013, Gynecologic oncology.

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study

R. Edwards, N. Finkler, D. Irwin, 2004, International Journal of Gynecologic Cancer.

Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience

R. Holloway, Sarfraz Ahmad, N. Finkler, 2012, Gynecological Surgery.

Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer

J. Edwards, R. Holloway, Sarfraz Ahmad, 2015, Molecular and Cellular Biochemistry.

Sonographic accuracy in the diagnosis of ovarian masses.

R. Knapp, N. Finkler, B. Benacerraf, 1990, The Journal of reproductive medicine.

Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients.

J. Edwards, R. Holloway, Sarfraz Ahmad, 2012, Cytotherapy.

Functional Characterization of a Fluorescent Highly Tumorigenic Ovarian Cancer Line to Test Cellular Therapy in Experimental Models

J. Edwards, R. Holloway, Sarfraz Ahmad, 2011, International Journal of Gynecologic Cancer.

Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging.

D. Cohn, R. Holloway, F. Backes, 2012, Gynecologic oncology.

Elevated CA 125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes.

C. Griffiths, R. Knapp, N. Finkler, 1988, Gynecologic oncology.

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125.

R. Knapp, M. Muto, A. Kassis, 1990 .

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC).

J. Yi, C. Aghajanian, M. Sovak, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC)

R. Glasspool, D. Dizon, P. Celano, 2008 .

Clinical-pathologic and morbidity analyses of Types 2 and 3 abdominal radical hysterectomy for cervical cancer.

R. Holloway, Sarfraz Ahmad, N. Finkler, 2007, Gynecologic oncology.

A prospective trial of primary surgical cytoreduction (CTR) for stage III–IV ovarian carcinoma

E. Jenison, C. Griffiths, N. Finkler, 1989 .

Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms.

R. Holloway, N. Finkler, T. Tran, 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Clinical Experience With Placental Site Trophoblastic Tumors at the New England Trophoblastic Disease Center

R. Berkowitz, N. Finkler, S. Driscoll, 1988, Obstetrics and gynecology.

Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.

R. Holloway, N. Finkler, G. Bigsby, 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.

J. Berek, T. Whiteside, P. Taylor, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

I. Vergote, J. Keck, C. Runowicz, 2010, International Journal of Gynecologic Cancer.

Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer

R. Glasspool, D. Dizon, P. Celano, 2012, International Journal of Gynecologic Cancer.

Metastatic choriocarcinoma in a viable intrauterine pregnancy treated with EMA-CO in the third trimester: a case report.

Sarfraz Ahmad, N. Finkler, M. Radi, 2011, The Journal of reproductive medicine.

Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment.

N. Finkler, 1991, The Journal of reproductive medicine.

Clinical experience with placental site trophoblastic tumors (PSTT) at the new england trophoblastic disease center (NETDC)

R. Berkowitz, N. Finkler, S. Driscoll, 1988 .

Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.

M. Squires, G. Konecny, Allison Upalawanna, 2015, The Lancet. Oncology.

Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.

D. Matei, I. Vergote, S. Kaye, 2009, European journal of cancer.

The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long‐term results

C. Griffiths, L. Parker, N. Finkler, 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer

N. Finkler, J. Kendrick, A. Gubbi, 2014, Expert review of anticancer therapy.

Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance.

Nazia Sultana, Sarfraz Ahmad, N. Sultana, 2009, Gynecologic oncology.

Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery.

D. Cohn, R. Holloway, F. Backes, 2013, Gynecologic oncology.

Mucinous adenocarcinomas of the vulva.

C. Griffiths, N. Finkler, J. Kasznica, 1995, Gynecologic oncology.

Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer.

R. Holloway, Sarfraz Ahmad, N. Finkler, 2007, Obstetrics and gynecology.

Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer

J. Edwards, R. Holloway, Sarfraz Ahmad, 2015, Molecular and Cellular Biochemistry.